Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Biopharmaceutical CMO Market?

The market size of biopharmaceutical CMO has seen a fast-paced expansion in the recent past. It is projected to escalate from a value of $24.81 billion in 2024 to $28.09 billion in 2025, growing at a compound annual growth rate (CAGR) of 13.2%. Factors such as the growing demand for biopharmaceuticals, increasing globalisation, a surge in healthcare spending, regulatory backing, and an uptick in research funding are accountable for this upswing during the historic period.

What Growth Rate Is Forecasted for the Biopharmaceutical CMO Market by 2029?

The market size of the biopharmaceutical CMO is projected to witness a swift expansion in the ensuing years, reaching $48.04 billion by 2029, growing at a CAGR of 14.4%. The predicted surge within this forecast period is primarily due to the increase in telehealth and remote trials, global health initiatives, and a rise in disposable income. Dominance of advanced therapies, digitalization and industry 4.0, continuous manufacturing, as well as sustainability and green practices are among the significant trends anticipated within this period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp

Which Key Companies Are Shaping the Future of the Biopharmaceutical CMO Market?

Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG

Which Factors Are Driving Demand in the Biopharmaceutical CMO Industry?

The growth of the biopharmaceutical CMO market is forecasted to be fueled by a rising elderly population. Individuals aged over 60 years are more prone to heart disease and related conditions than their younger counterparts. This rise in elderly individuals can be attributed to improvements in healthcare, a decrease in birth rates, and the aging of the baby boomer generation. The growing elderly demographic is increasing the demand for biopharmaceutical treatments aimed at age-linked illnesses like cardiovascular disorders. This is where biopharmaceutical CMOs step in, offering bespoke manufacturing capabilities for intricate biologics and customized medicines to meet these requirements. For example, in January 2024, the Population Reference Bureau, a non-profit organization based in the US, projected that the American population aged 65 and above will increase from 58 million in 2022 to 82 million by 2050. Hence, the rising geriatric population is driving the growth of the biopharmaceutical CMO market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp

How Is the Biopharmaceutical CMO Market Segmented by Several Divisions?

The biopharmaceutical cmo market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones

What are the Emerging Market Trends Driving the Growth of the Biopharmaceutical CMO Industry?

The rise of technology is a significant trend in the biopharmaceutical CMO industry. Leading companies in this market are making noteworthy progress in their technological capabilities and research and development, utilizing IoT. The concept of Internet of Things (IoT) is the use of interconnected sensors and actuators to monitor and control the environment, objects moving within it, and the individuals involved. The integrated sensors, actuators, and other pieces in manufacturing equipment and networked computer systems can generate a vast quantity of data. This data can be analyzed to uncover insights and possibilities to enhance manufacturing efficiency, automate overseeing and control tasks, and facilitate adaptable manufacturing operations. For example, in February 2022, M2Cloud, a Korean bio-cold chain tech firm, in cooperation with Thales, a French IoT communication module specialist, created an IoT-based LTE system for tracking biopharmaceuticals. The system allows for real-time monitoring of freezers, cool storage facilities, delivery boxes, etc., providing remote, real-time information on temperature and location with just the flip of a switch. This type of technologically advanced biopharmaceutical management even enhances the safety of pharmaceutical products.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Which Regions Are Driving Growth in the Biopharmaceutical CMO Market?

North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7771

This Report Delivers Insight On:

1. How big is the biopharmaceutical cmo market, and how is it changing globally?

2. Who are the major companies in the biopharmaceutical cmo market, and how are they performing?

3. What are the key opportunities and risks in the biopharmaceutical cmo market right now?

4. Which products or customer segments are growing the most in the biopharmaceutical cmo market?

5. What factors are helping or slowing down the growth of the biopharmaceutical cmo market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model